ABVX compared with IBRX: revenue, margins and what each company keeps, and the suppliers and customers both name

ABVXAbivax S.A.

Mkt capRevenueRevenue

IBRXImmunityBio, Inc.

Mkt capRevenueRevenue

Compare

ABVXAbivax S.A.

IBRXImmunityBio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ABVX: latest quarter not drawable. IBRX: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

ABVX, solidIBRX, dashed

ABVXAbivax S.A.

86.58▼−2.78%· post 86.59

Mkt cap$6.0BRevenue—Revenue—

IBRXImmunityBio, Inc.

8.29▼−5.15%· post 8.27

ClosedOct 30 '26

Mkt cap$8.8BRevenue$51MQ2 FY26Revenue$140MFY25

Compare

ClosedOct 30 '26

ABVXAbivax S.A.

IBRXImmunityBio, Inc.

86.58▼−2.78%post 86.59

Price

8.29▼−5.15%post 8.27

$6.0B

Mkt cap

$8.8B

—

Revenue

$51MQ2 FY26

—

Revenue

$140MFY25

ABVX86.58▼−2.78%vsIBRX8.29▼−5.15%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ABVX 0

None

Shared 0

No disclosed counterparties: ABVX.

Only IBRX 3

HCWBHCW Biologicscustomer

—Accord Healthcareunlistedcustomer

—BioPharma & Cigalah Healthcareunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR